Jacobio Pharmaceuticals reports September share capital, treasury share changes

Jacobio Pharmaceuticals Group announced that its authorized share capital remained stable at $100,000, consisting of 1,000,000,000 ordinary shares with a par value of $0.0001 each, as of September 30, 2025. There were no increases or decreases in the authorized share capital during the reporting month.

The company's issued shares (excluding treasury shares) decreased by 216,000, from 788,624,880 at the beginning of September to 788,408,880 by month-end. This decline was primarily due to two share repurchase events. On September 24, 2025, the company repurchased 52,500 shares at HK$9.47 per share. A second repurchase occurred on September 25, 2025, involving 163,500 shares at HK$9.17 per share. These repurchases led to an increase in treasury shares by 216,000, bringing the total number of treasury shares to 3,346,200 from 3,130,200. Consequently, the total number of issued shares remained at 791,755,080.